Vaginal Progesterone to Reduce the Risk of Another Preterm Birth

Mise à jour : Il y a 4 ans
Référence : NCT00086177

Femme Homme

Extrait

This research study is being conducted at over 12 pregnancy research centers in the US. The study will compare an investigational treatment with a placebo (a treatment without medication). Neither the investigators nor the patients in the trial will know which treatment has been assigned. All study medications will be given vaginally once a day. Treatment will begin before pregnancy week 23 and will continue until the end of pregnancy week 36.


Critère d'inclusion

  • pregnancy

Liens